Thermo Fisher Scientific

Driven by the success of COVID-19 vaccines, mRNA products are expanding drug developers’ pipelines.

A short guide to strengthening raw materials supply chains in the biopharma industry, featuring Luis Bianchi Pintos from Thermo Fisher Scientific.

We catch up with Christine Callahan from Thermo Fisher Scientific about how suppliers and customers need to reimagine their business models.

We spoke to Prateek Gadhoke, Global Head of Specialty Care Procurement at Sanofi, to ask what makes a strong supply chain.

In this eBook, experts give their views on enhancing downstream purification.

The increasing complexity of biologics raises significant manufacturing challenges – not least regarding cost control and downstream purification.

Amgen has brought the Multi-Attribute Method (MAM) into the mainstream, but what’s next for this analytical workflow. Click to read article

Amgen developed the Multi-Attribute Method (MAM) to obtain high-fidelity understanding of the quality of its own biologics. Click to read article

Gene therapies look set to revolutionize the field of medicine – and AAVs have emerged as the vector of choice.

Manufacturers have a unique opportunity to take advantage of the cost and time advantages associated with Oligo(dT) – the adoption process is simple.